pharma · Non-muscle Invasive Bladder Cancer · Non-Muscle Invasive Bladder Cancer
ImmunityBio
Immunitybio Ireland Limited
ImmunityBio clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
San Diego, USA HQ
2014 Founded
625 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2014
- Employees
- 625
- Programs
- 2
- Drugs
- 5
- Patents
- 0
ImmunityBio projects
2 ClinicalTrials.gov programs sponsored by ImmunityBio.
ImmunityBio has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does ImmunityBio have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.